Article thumbnail

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer

By Joyce F. Liu, Isabelle Ray-Coquard, Frederic Selle, Andrés M. Poveda, David Cibula, Hal Hirte, Felix Hilpert, Francesco Raspagliesi, Laurence Gladieff, Philipp Harter, Salvatore Siena, Josep Maria del Campo, Isabelle Tabah-Fisch, Joseph Pearlberg, Victor Moyo, Kaveh Riahi, Rachel Nering, William Kubasek, Bambang Adiwijaya, Akos Czibere, R. Wendel Naumann, Robert L. Coleman, Ignace Vergote, Gavin MacBeath and Eric Pujade-Lauraine
Publisher: American Society of Clinical Oncology (ASCO)
Year: 2017
DOI identifier: 10.1200/jco.2016.67.1891
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.